Heparin-insensitive method for determining direct coagulation factor inhibitors

US8685636B2 · kind B2 · utility

Assignee

• Siemens Healthcare Diagnostics Products GmbH · DE

Inventors

• Konrad Braun · Allendorf (Lumda), DE
• Wolfgang Klein · Zorneding, DE
• Norbert Zander · Marburg, DE
• Michael Timme · Hörstel, DE

Key dates

• Filing date: Feb 6, 2012
• Grant date: Apr 1, 2014
• Expiry date: Feb 20, 2032

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2500/02
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The invention is in the field of coagulation diagnostics and relates to a heparin-insensitive method for determining direct coagulation factor inhibitors in a sample, in particular direct thrombin and factor Xa inhibitors.